About 17 600 results
Past year
Open links in new tab
WEBDec 5, 2023 · We are hiring! Join Our Team. CURRENT OPENINGS. Our Investors. Eligo Bioscience is deploying in vivo gene editing technologies against microbiome targets to address diseases with high unmet needs.
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for ...
Xavier Duportet modifie les bactéries pour traiter les maladies
- Some results have been removed